<html>
  <body>
    <p>
      <span font-family="times" font-size="11.04" y="45.72" bbox="[[273, 322], [34, 45]]">Chapter 16</span>
      <span font-family="times" font-size="11.04" y="45.72" bbox="[[443, 447], [34, 45]]">I</span>
      <span font-family="times" font-size="11.04" y="45.72" bbox="[[446, 470], [34, 45]]">PCC </span>
      <span font-family="times" font-size="11.04" y="45.72" bbox="[[470, 494], [34, 45]]">AR6 </span>
      <span font-family="times" font-size="11.04" y="45.72" bbox="[[494, 523], [34, 45]]">WGIII</span>
    </p>
    <p>
      <span font-family="times" font-size="11.04" y="82.34" bbox="[[72, 308], [71, 82]]">ultimately no one having the effective privilege of us</span>
      <span font-family="times" font-size="11.04" y="82.34" bbox="[[308, 341], [71, 82]]">ing the </span>
      <span font-family="times" font-size="11.04" y="82.34" bbox="[[342, 373], [71, 82]]">results </span>
      <span font-family="times" font-size="11.04" y="82.34" bbox="[[373, 526], [71, 82]]">of biomedical research. Reitzig et </span>
      <span font-family="times" font-size="11.04" y="96.26" bbox="[[72, 85], [85, 96]]">al. </span>
      <span font-family="times" font-size="11.04" y="96.26" bbox="[[87, 116], [85, 96]]">(2007)</span>
      <span font-family="times" font-size="11.04" y="96.26" bbox="[[120, 525], [85, 96]]">describe the damaging effects of extreme business strategies employing patents, such as </span>
      <span font-family="times" font-size="11.04" y="110.18" bbox="[[72, 104], [99, 110]]">patent t</span>
      <span font-family="times" font-size="11.04" y="110.18" bbox="[[104, 139], [99, 110]]">rolling. </span>
      <span font-family="times" font-size="11.04" y="130.1" bbox="[[72, 525], [119, 130]]">IP protection and enforcement in general may have different impacts on economic growth in different </span>
      <span font-family="times" font-size="11.04" y="144.02" bbox="[[72, 159], [132, 144]]">types of countries </span>
      <span font-family="times" font-size="11.04" y="144.02" bbox="[[163, 323], [132, 144]]">
        <i>(limited evidence, high agreement</i>
      </span>
      <span font-family="times" font-size="11.04" y="144.02" bbox="[[323, 525], [132, 144]]">). There has been a significant degree of </span>
      <span font-family="times" font-size="11.04" y="157.94" bbox="[[72, 308], [146, 157]]">harmonisation and cooperation between national IP sy</span>
      <span font-family="times" font-size="11.04" y="157.94" bbox="[[308, 526], [146, 157]]">stems over time. The most recent milestone is the </span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[72, 124], [160, 171]]">1994 WTO </span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[125, 213], [160, 171]]">agreement on Trade</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[213, 217], [160, 171]]">-</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[217, 432], [160, 171]]">Related Aspects of Intellectual Property Rights (</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[432, 464], [160, 171]]">TRIPS </span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[465, 473], [160, 171]]">A</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[473, 514], [160, 171]]">greement</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[514, 517], [160, 171]]">)</span>
      <span font-family="times" font-size="11.04" y="171.86" bbox="[[520, 526], [160, 171]]">, </span>
      <span font-family="times" font-size="11.04" y="185.78" bbox="[[72, 525], [174, 185]]">entered into by all members of the World Trade Organisation (WTO), and which sets down minimum </span>
      <span font-family="times" font-size="11.04" y="199.7" bbox="[[72, 135], [188, 199]]">standards for t</span>
      <span font-family="times" font-size="11.04" y="199.7" bbox="[[135, 525], [188, 199]]">he regulation by national governments of many forms of intellectual property as applied </span>
      <span font-family="times" font-size="11.04" y="213.62" bbox="[[72, 265], [202, 213]]">to nationals of other WTO member nations </span>
      <span font-family="times" font-size="11.04" y="213.62" bbox="[[266, 323], [202, 213]]">(WTO 1994)</span>
      <span font-family="times" font-size="11.04" y="213.62" bbox="[[323, 526], [202, 213]]">. Developing countries successfully managed </span>
      <span font-family="times" font-size="11.04" y="227.42" bbox="[[72, 192], [216, 227]]">to include some flexibilitie</span>
      <span font-family="times" font-size="11.04" y="227.42" bbox="[[192, 525], [216, 227]]">s into TRIPS both in terms of timing of legislative reform and in terms of </span>
      <span font-family="times" font-size="11.04" y="241.37" bbox="[[72, 525], [230, 241]]">the content of the reforms. In an attempt to understand the effects of the introduction of TRIPS, Falvey </span>
      <span font-family="times" font-size="11.04" y="255.29" bbox="[[72, 97], [244, 255]]">et al. </span>
      <span font-family="times" font-size="11.04" y="255.29" bbox="[[98, 127], [244, 255]]">(2006)</span>
      <span font-family="times" font-size="11.04" y="255.29" bbox="[[131, 525], [244, 255]]">find that the effect of IP protection on growth is positively and significantly related to </span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[72, 138], [258, 269]]">growth for low</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[138, 141], [258, 269]]">-</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[144, 182], [258, 269]]">and high</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[182, 186], [258, 269]]">-</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[186, 346], [258, 269]]">income countries, but not for middle</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[347, 350], [258, 269]]">-</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[350, 426], [258, 269]]">income countries</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[426, 519], [258, 269]]">. They argue that low</span>
      <span font-family="times" font-size="11.04" y="269.21" bbox="[[519, 523], [258, 269]]">-</span>
      <span font-family="times" font-size="11.04" y="283.13" bbox="[[72, 393], [272, 283]]">income countries benefit from increased technology flows, but middle</span>
      <span font-family="times" font-size="11.04" y="283.13" bbox="[[394, 397], [272, 283]]">-</span>
      <span font-family="times" font-size="11.04" y="283.13" bbox="[[397, 526], [272, 283]]">income countries may have </span>
      <span font-family="times" font-size="11.04" y="297.05" bbox="[[72, 409], [286, 297]]">offsetting losses from the reduced scope for imitation. Note that Falvey et al. </span>
      <span font-family="times" font-size="11.04" y="297.05" bbox="[[410, 439], [286, 297]]">(2006)</span>
      <span font-family="times" font-size="11.04" y="297.05" bbox="[[441, 526], [286, 297]]">do not break down </span>
      <span font-family="times" font-size="11.04" y="310.97" bbox="[[72, 525], [299, 310]]">their results in different technological areas and they do not focus on innovation, but instead growth. It </span>
      <span font-family="times" font-size="11.04" y="324.89" bbox="[[72, 219], [313, 324]]">has been argued that the increasin</span>
      <span font-family="times" font-size="11.04" y="324.89" bbox="[[219, 526], [313, 324]]">gly globalised IP regime through initiatives like the TRIPS agreement </span>
      <span font-family="times" font-size="11.04" y="338.81" bbox="[[72, 525], [327, 338]]">will diminish prospects for technology transfer and competition in developing countries, particularly </span>
      <span font-family="times" font-size="11.04" y="352.73" bbox="[[72, 448], [341, 352]]">for several important technology areas related to meeting sustainable development ne</span>
      <span font-family="times" font-size="11.04" y="352.73" bbox="[[449, 466], [341, 352]]">eds </span>
      <span font-family="times" font-size="11.04" y="352.73" bbox="[[466, 526], [341, 352]]">(Maskus and </span>
      <span font-family="times" font-size="11.04" y="366.65" bbox="[[72, 145], [355, 366]]">Reichman 2017)</span>
      <span font-family="times" font-size="11.04" y="366.65" bbox="[[145, 147], [355, 366]]">.</span>
      <span font-family="times" font-size="11.04" y="386.57" bbox="[[72, 169], [375, 386]]">In principle, patent ho</span>
      <span font-family="times" font-size="11.04" y="386.57" bbox="[[169, 525], [375, 386]]">lders are not required to take their protected invention into use, and neither have </span>
      <span font-family="times" font-size="11.04" y="400.51" bbox="[[72, 428], [389, 400]]">the obligation to allow (i.e., license) others to use the inventions in question </span>
      <span font-family="times" font-size="11.04" y="400.51" bbox="[[430, 526], [389, 400]]">
        <i>(high evidence, high </i>
      </span>
      <span font-family="times" font-size="11.04" y="414.43" bbox="[[72, 122], [403, 414]]">
        <i>agreement)</i>
      </span>
      <span font-family="times" font-size="11.04" y="414.43" bbox="[[122, 382], [403, 414]]">. Studies have shown that the way patent holders use their p</span>
      <span font-family="times" font-size="11.04" y="414.43" bbox="[[382, 526], [403, 414]]">atent differs considerably across </span>
      <span font-family="times" font-size="11.04" y="428.35" bbox="[[72, 525], [417, 428]]">industrial sectors: in pharmaceutics, patents are typically used to be the only producer of a certain good </span>
      <span font-family="times" font-size="11.04" y="442.27" bbox="[[72, 525], [431, 442]]">(and obtain monopoly rents), while in industries like computers, semiconductors, and communications, </span>
      <span font-family="times" font-size="11.04" y="456.19" bbox="[[72, 131], [445, 456]]">patents are of</span>
      <span font-family="times" font-size="11.04" y="456.19" bbox="[[132, 309], [445, 456]]">ten used to strengthen positions in cross</span>
      <span font-family="times" font-size="11.04" y="456.19" bbox="[[309, 313], [445, 456]]">-</span>
      <span font-family="times" font-size="11.04" y="456.19" bbox="[[313, 526], [445, 456]]">licensing negotiations and to generate licensing </span>
      <span font-family="times" font-size="11.04" y="470.11" bbox="[[72, 107], [459, 470]]">income </span>
      <span font-family="times" font-size="11.04" y="470.11" bbox="[[107, 251], [459, 470]]">(Cohen et al. 2000; Foray 2004)</span>
      <span font-family="times" font-size="11.04" y="470.11" bbox="[[251, 525], [459, 470]]">. There are also companies that predominantly obtain patents </span>
      <span font-family="times" font-size="11.04" y="484.03" bbox="[[72, 331], [472, 484]]">for defensive reasons: they seek freedom to design and ma</span>
      <span font-family="times" font-size="11.04" y="484.03" bbox="[[331, 526], [472, 484]]">nufacture, and by owning a patent portfolio </span>
      <span font-family="times" font-size="11.04" y="497.95" bbox="[[72, 500], [486, 497]]">themselves, they hope to prevent that they become the target of litigation by other patent holders </span>
      <span font-family="times" font-size="11.04" y="497.95" bbox="[[500, 526], [486, 497]]">(Hall </span>
      <span font-family="times" font-size="11.04" y="511.75" bbox="[[72, 159], [500, 511]]">and Ziedonis 2001)</span>
      <span font-family="times" font-size="11.04" y="511.75" bbox="[[159, 525], [500, 511]]">. Patents are often used strategically to impede the development and diffusion of </span>
      <span font-family="times" font-size="11.04" y="525.67" bbox="[[72, 416], [514, 525]]">competing, alternative products, processes or services, by employing strategie</span>
      <span font-family="times" font-size="11.04" y="525.67" bbox="[[417, 526], [514, 525]]">s known as &#8216;blanketing&#8217; </span>
      <span font-family="times" font-size="11.04" y="539.59" bbox="[[72, 130], [528, 539]]">and &#8216;fencing&#8217;</span>
      <span font-family="times" font-size="11.04" y="539.59" bbox="[[133, 220], [528, 539]]">(Grandstrand 2000)</span>
      <span font-family="times" font-size="11.04" y="539.59" bbox="[[220, 349], [528, 539]]">, although the research is not </span>
      <span font-family="times" font-size="11.04" y="539.59" bbox="[[349, 476], [528, 539]]">specific to the climate space.</span>
      <span font-family="times" font-size="11.04" y="559.54" bbox="[[72, 525], [548, 559]]">There are notable but specific exceptions to the general principle that patent holders are not obliged to </span>
      <span font-family="times" font-size="11.04" y="573.46" bbox="[[72, 525], [562, 573]]">license their patent to others. These exceptions include the compulsory license, Fair, Reasonable and </span>
      <span font-family="times" font-size="11.04" y="587.38" bbox="[[72, 90], [576, 587]]">Non</span>
      <span font-family="times" font-size="11.04" y="587.38" bbox="[[90, 94], [576, 587]]">-</span>
      <span font-family="times" font-size="11.04" y="587.38" bbox="[[94, 313], [576, 587]]">discriminatory (FRAND) policies, and stateme</span>
      <span font-family="times" font-size="11.04" y="587.38" bbox="[[313, 424], [576, 587]]">nt on licences of right </span>
      <span font-family="times" font-size="11.04" y="587.38" bbox="[[427, 526], [576, 587]]">
        <i>(high evidence, high </i>
      </span>
      <span font-family="times" font-size="11.04" y="601.3" bbox="[[72, 124], [590, 601]]">
        <i>agreement).</i>
      </span>
      <span font-family="times" font-size="11.04" y="601.3" bbox="[[128, 525], [590, 601]]">While patent holders are, as stated above, in principle free to choose not to license their </span>
      <span font-family="times" font-size="11.04" y="615.22" bbox="[[72, 525], [604, 615]]">innovation, there are three important exceptions to this. First, most national patent laws have provisions </span>
      <span font-family="times" font-size="11.04" y="629.14" bbox="[[72, 525], [618, 629]]">for compulsory licensing, meaning that a government allows someone else to produce a patented </span>
      <span font-family="times" font-size="11.04" y="643.06" bbox="[[72, 478], [632, 643]]">product or process without the consent of the patent holder, or plans to use the patent</span>
      <span font-family="times" font-size="11.04" y="643.06" bbox="[[478, 482], [632, 643]]">-</span>
      <span font-family="times" font-size="11.04" y="643.06" bbox="[[482, 526], [632, 643]]">protected </span>
      <span font-family="times" font-size="11.04" y="656.98" bbox="[[72, 141], [645, 656]]">invention itself </span>
      <span font-family="times" font-size="11.04" y="656.98" bbox="[[141, 199], [645, 656]]">(WTO 2020)</span>
      <span font-family="times" font-size="11.04" y="656.98" bbox="[[199, 525], [645, 656]]">. Compulsory licenses may be issued in cases of public interest or events </span>
      <span font-family="times" font-size="11.04" y="670.9" bbox="[[72, 171], [659, 670]]">of abuse of the patent </span>
      <span font-family="times" font-size="11.04" y="670.9" bbox="[[171, 462], [659, 670]]">(Biadgleng 2009; World Intellectual Property Organization 2008)</span>
      <span font-family="times" font-size="11.04" y="670.9" bbox="[[463, 526], [659, 670]]">. Compulsory </span>
      <span font-family="times" font-size="11.04" y="684.82" bbox="[[72, 525], [673, 684]]">licensing is explicitly allowed in the WTO TRIPS agreement, and its use in context of medicine (for </span>
      <span font-family="times" font-size="11.04" y="698.74" bbox="[[72, 151], [687, 698]]">instance to contro</span>
      <span font-family="times" font-size="11.04" y="698.74" bbox="[[151, 525], [687, 698]]">l diseases of public health importance, including HIV, tuberculosis and malaria) is </span>
      <span font-family="times" font-size="11.04" y="712.68" bbox="[[72, 335], [701, 712]]">further clarified in the &#8216;DOHA Declaration&#8217; from 2001 </span>
      <span font-family="times" font-size="11.04" y="712.68" bbox="[[338, 480], [701, 712]]">(Reichman 2009; WHO 2020)</span>
      <span font-family="times" font-size="11.04" y="712.68" bbox="[[480, 526], [701, 712]]">. Second, </span>
      <span font-family="times" font-size="11.04" y="726.6" bbox="[[72, 109], [715, 726]]">standard</span>
      <span font-family="times" font-size="11.04" y="726.6" bbox="[[109, 113], [715, 726]]">-</span>
      <span font-family="times" font-size="11.04" y="726.6" bbox="[[113, 525], [715, 726]]">setting organisations have policies to include patented inventions in their standards only if the </span>
      <span font-family="times" font-size="11.04" y="740.52" bbox="[[72, 227], [729, 740]]">patent holder is willing to commit</span>
      <span font-family="times" font-size="11.04" y="740.52" bbox="[[231, 443], [729, 740]]">FRAND licensing conditions for those patents </span>
      <span font-family="times" font-size="11.04" y="740.52" bbox="[[444, 520], [729, 740]]">(Contreras 2015)</span>
      <span font-family="times" font-size="11.04" y="740.52" bbox="[[520, 526], [729, 740]]">. </span>
      <span font-family="times" font-size="11.04" y="754.44" bbox="[[72, 423], [743, 754]]">While a patent holder can still choose not to make such a commitment, by do</span>
      <span font-family="times" font-size="11.04" y="754.44" bbox="[[423, 526], [743, 754]]">ing so, its patent is no </span>
    </p>
  </body>
</html>
